Innovate drugs faster & smarter
Revolutionize Drug Discovery Through the Intelligent Application of AI
AI-driven drug discovery (AIDD) integrates advanced machine learning and computational modeling to streamline therapeutic development
AIDD leverages deep learning and generative models to transform the drug discovery pipeline—including target identification, molecular design, and preclinical evaluation, uncovering novel therapeutics with greater speed, precision, and scalability.
At KumiChem™, we deliver a human-centered platform that amplifies the AIDD process through high-level automation and the seamless integration of expert knowledge with AI-driven innovation.
Applicablefor Everyone
Jumpstartwith Templates
FlexibleWorkflow Builder
KumiChem™ Automating AIDD workflows
Knowledge - Data - Models - People
No matter who you are in the world of drug discovery,
we're here to help you move faster, work smarter, and explore further
For Pharma Teams
Want to boost productivity on existing targets or explore brand-new ones? Our smart AI tools help you accomplish more, from target validation to ligand design, with speed and confidence.
For PI & University Labs
Bring the power of AI into your everyday research. Our tools are easy to adopt, flexible, and designed to supercharge your lab's discovery workflows.
For Curious Minds & Learners
Just getting started or looking to stay up to date? Dive into the latest in drug discovery and AI with resources that make complex science simple and exciting.
Find the Best Solutions
Our system explores vast chemical and biological spaces, compares strategies, and recommends optimal paths — so you can make smarter decisions, faster.
Seamless & Scalable Workflows
Easily plug into your existing processes. Whether you're running a single experiment or scaling across projects, our platform flexes to your needs.
Collaboration-Ready
We've already begun working with real-world labs to co-create smarter solutions for delivering better medicines — faster. Now, we're looking for ambitious, like-minded partners to collaborate with and grow together.
News
Stay up to date with our latest news and product updates.
Dr. Yamada Takeshi Joins as Scientific Advisor
Dr. Takeshi Yamada, Lecturer at the Institute of Science Tokyo, Nucleic Acid & Peptide Drug Discovery and Therapeutics Center (TIDE), has officially joined us as a Scientific Advisor effective November 2025. His deep expertise in nucleic acid drugs will strengthen the development of KumiChemTM, accelerating practical drug discovery with AI.
News №013
Launches Joint Research with Osaka University
On November 1, We initiated a collaborative study "KumiChem: Research on Workflow and Automated Generation in Early Drug Discovery and Preclinical Development" with Professor Mizuguchi's laboratory at Osaka University. The partnership combines KumiChem's AI platform with academic expertise to advance automated drug discovery workflows from early research through preclinical stages.
News №012
KumiChem Joins LINK-J Life Science Network
October 2025, DLeader joined LINK-J (Life Science Innovation Network Japan), connecting with 700+ member organizations in Japan's leading life science ecosystem. The membership accelerates KumiChem's beta launch of its AI platform, which delivers 160x faster drug discovery and $100M in cost savings per program. Joining LINK-J strengthens DLeader’s position in Japan's pharmaceutical innovation landscape.
News №011
KumiChem Pitches at Osaka Global Startup Expo
On September 18, Founder and CEO Qingwen Chen presented KumiChem's automated drug discovery workflow at the Global Startup Expo in Osaka, a premier side event of EXPO 2025 hosted by Hankyu Hanshin and JETRO. The pitch showcased KumiChem's AI-driven platform for accelerating pharmaceutical research to an international audience of investors and industry leaders.
News №010
OCTOPUS Rack Design Contest Grant Prize Winner
Our UI/UX designer Ann Grishunova won the Grand Prize at the OCTOPUS (Osaka University Compute & sTOrage Platform Urging open Science) Rack Design Contest 2025 with her "Blossom" concept, symbolizing AI in innovation, growth, and the beauty of the world. View detailed
News №009
DLeader Joins Techstars Tokyo 2025 Class
DLeader has been selected to join Techstars, one of the world's leading startup accelerators, from a highly competitive pool of applicants spanning 120 countries, with an acceptance rate of less than 1%. View detailed
News №008
HVC Kyoto 2025
Our AI-driven drug discovery platform, KumiChem™, has been selected to participate in HVC Kyoto 2025, a leading healthcare venture conference in Japan that connects cutting-edge startups with investors, industry leaders, and global partners to accelerate innovation in life sciences. View detailed
News №007
Prof. Nakatani Joins as Scientific Advisor
We are honored to welcome Prof. Nakatani, a pioneer in small-molecule targeting of nucleic acids, as a scientific advisor. His groundbreaking research and passion for scientific innovation will play a pivotal role in shaping the next-gen drug discovery.
News №006
Ibaraki Tech Planter Talk
On February 8, 2025, at the Ibaraki Tech Planter Lightning Talk hosted by Leave a Nest, we presented the vision of our AI agent drug discovery platform, KumiChemTM. The event connected us with innovators, investors, and researchers eager to transform science through technology.
News №005
EXPO 2025 Selection
Our message, "Streamlining in-silico drug discovery workflows for a smarter, healthier future" was selected for Future Voyage at Expo 2025 Osaka, Kansai (Oct 3-7). View detailed
News №004
Prof. Mizuguchi Joins as Scientific Advisor
Spring 2024 marked the start of our collaboration with Prof. Mizuguchi at the University of Osaka, an internationally recognized leader in computational biology. His expertise in bioinformatics and AI-assisted drug design will help push the boundaries of in-silico research, opening new opportunities together.
News №003
Angel Investment
In June 2024, DLeader secured a ¥10 million angel investment from First Domino. This funding will support the development of our proprietary AI-driven drug discovery platform.
News №002
Official Launch
On April 12, 2024, DLeader officially launched in Osaka with Qingwen Chen as CEO. The company was founded to revolutionize AI-based drug discovery, aiming to support real-world therapies with intelligent automation.
News №001Frequently Asked Questions
What tasks can be performed with the KumiChem™ platform?
The KumiChem™ platform is designed to support a wide range of practical, AI-driven tasks in drug discovery and development.
Some examples like: QSAR modeling, ASO (Antisense Oligonucleotide) design, data curation (cleaning, organizing, and validating chemical and biological datasets for more robust model training), custom model training (building tailored machine learning models using proprietary or domain-specific data to solve unique R&D challenges)
How is KumiChem™ different from other platforms?
Who should use KumiChem™ platform?
How can I get early access to KumiChem™?
Didn't find the answer to your question?
Ask us a question and we will be happy to answer it! We will send the answer to your email
